The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA
Aim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy or in combination with hydrochlorothiazide or amlodipine, in real clinical practice in patients with diagnosed arterial hypertension who have not reached the target levels of blood pressure (BP).Material and methods. T...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2020-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227592475869184 |
|---|---|
| author | O. D. Ostroumova A. I. Kochetkov F. T. Ageev G. S. Anikin E. Kh. Akhmetzyanova E. I. Bezuglova A. B. Bekoeva N. Yu. Borovkova N. G. Vinogradova E. V. Gorbunova A. A. Goryacheva E. S. Zhugrova O. A. Kislyak S. M. Klyashev V. P. Kuzmin A. A. Lipchenko G. V. Matyushin E. A. Mikhailova V. A. Nevzorova A. G. Obrezan T. A. Petrichko M. M. Petrova A. N. Reider A. N. Repin V. I. Sadovoy N. P. Sanina A. E. Skripchenko R. I. Stryuk I. V. Faiyance L. A. Khaisheva N. R. Khasanov R. A. Khokhlov E. E. Tsareva A. L. Cherkashina I. I. Shaposhnik I. A. Shelestova R. N. Shepel E. V. Shikh D. A. Yakhontov |
| author_facet | O. D. Ostroumova A. I. Kochetkov F. T. Ageev G. S. Anikin E. Kh. Akhmetzyanova E. I. Bezuglova A. B. Bekoeva N. Yu. Borovkova N. G. Vinogradova E. V. Gorbunova A. A. Goryacheva E. S. Zhugrova O. A. Kislyak S. M. Klyashev V. P. Kuzmin A. A. Lipchenko G. V. Matyushin E. A. Mikhailova V. A. Nevzorova A. G. Obrezan T. A. Petrichko M. M. Petrova A. N. Reider A. N. Repin V. I. Sadovoy N. P. Sanina A. E. Skripchenko R. I. Stryuk I. V. Faiyance L. A. Khaisheva N. R. Khasanov R. A. Khokhlov E. E. Tsareva A. L. Cherkashina I. I. Shaposhnik I. A. Shelestova R. N. Shepel E. V. Shikh D. A. Yakhontov |
| author_sort | O. D. Ostroumova |
| collection | DOAJ |
| description | Aim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy or in combination with hydrochlorothiazide or amlodipine, in real clinical practice in patients with diagnosed arterial hypertension who have not reached the target levels of blood pressure (BP).Material and methods. The study was a non-intervention, prospective, multicenter, comparative, observational, epidemiological program, which was carried out in Russian medical institutions. The total patient population in which the prescribed therapy was administered included 1933 people (758 men and 1175 women, mean age 57.0-59.3 years). Participants were followed-up for 12 weeks. The change in office BP was evaluated on the 4th and 12th week.Results. Significant (p<0.001 in all cases) change in office BP compared with the initial data were recorded in all study groups of therapy already at 4 weeks of treatment and became even more pronounced at 12 weeks. In the telmisartan monotherapy group, BP decreased from 155.7±10.7/92.2±7.6 mm Hg to 131.4±12.1/80.8±7.3 mm Hg at the end of the 4th week and to 125.3±7.6/78.2±6.1 mm Hg – at the end of the 12th week. Similarly, after treatment with the combination of telmisartan and hydrochlorothiazide, BP decreased from 162.7±12.6/94.3±7.9 mm Hg to 133.2±12.5/81.6±8.4 mmHg at the end of the 4th week and to 126.0±7.8/78.4±6.7 mm Hg – at the end of the 12th week. In telmisartan/amlodipine group, a decrease in BP also occurred, from 162.5±13.2/94.6±8.6 mm Hg to 132.8±14.5/81.3±7.5 mm Hg on the 4th week and to 125.4±8.7/78.4±5.6 mm Hg at the end of follow up (12 weeks). The proportion of patients who reached the target BP (<140/90 mm Hg) after treatment with telmisartan as monotherapy was 91.7%, after treatment with telmisartan+hydrochlorothiazide – 89.6%, after treatment with telmisartan+amlodipine – 92.8%. Throughout the program, prescribed therapy was well tolerated by patients. During the study, 47 adverse events (AEs) were recorded in 36 patients: 31 AEs with telmisartan monotherapy, 5 AEs with telmisartan/hydrochlorothiazide combination, and 11 AEs with telmisartan/amlodipine combination. Most of the AEs registered during the trial resolved by the end of the study, in four cases the date of AEs resolve is unknown, in two cases, at the time of completion of the study, AEs continued.Conclusion. In the TAINA study a high antihypertensive efficacy and a comparable favorable safety and tolerability profile of telmisartan, used as monotherapy and in combination with hydrochlorothiazide or amlodipine was determined. |
| format | Article |
| id | doaj-art-9a89b6f41c844d00b164e671e6fe74c3 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2020-05-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-9a89b6f41c844d00b164e671e6fe74c32025-08-23T10:00:32ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532020-05-0116217519010.20996/1819-6446-2020-04-071729The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINAO. D. Ostroumova0A. I. Kochetkov1F. T. Ageev2G. S. Anikin3E. Kh. Akhmetzyanova4E. I. Bezuglova5A. B. Bekoeva6N. Yu. Borovkova7N. G. Vinogradova8E. V. Gorbunova9A. A. Goryacheva10E. S. Zhugrova11O. A. Kislyak12S. M. Klyashev13V. P. Kuzmin14A. A. Lipchenko15G. V. Matyushin16E. A. Mikhailova17V. A. Nevzorova18A. G. Obrezan19T. A. Petrichko20M. M. Petrova21A. N. Reider22A. N. Repin23V. I. Sadovoy24N. P. Sanina25A. E. Skripchenko26R. I. Stryuk27I. V. Faiyance28L. A. Khaisheva29N. R. Khasanov30R. A. Khokhlov31E. E. Tsareva32A. L. Cherkashina33I. I. Shaposhnik34I. A. Shelestova35R. N. Shepel36E. V. Shikh37D. A. Yakhontov38Russian Medical Academy of Continuous Professional Education; I.M. Sechenov First Moscow State Medical University (Sechenov University)Russian Medical Academy of Continuous Professional EducationNational Medical Research Center of CardiologyI.M. Sechenov First Moscow State Medical University (Sechenov University)Bashkir State Medical UniversityCity Outpatient Сlinic №5City Consultative and Diagnostic Center №1Privolzhsky Research Medical UniversityPrivolzhsky Research Medical UniversityResearch Institute for Complex Issues of Cardiovascular DiseasesMedical and Diagnostic Clinic “CardioVita”; Smolensk State Medical UniversityMultidisciplinary Medical Diagnostic Center “MSCh 157”Pirogov Russian National Research Medical UniversityTyumen State Medical UniversitySamara Regional Clinical Cardiology Dispensary“New Hospital”; Ural State Medical UniversityRegional Clinical HospitalSaratov City Outpatient Clinic №2Pacific State Medical UniversityInternational Medical Center SOGAZ; St. Petersburg State UniversityCity Outpatient Clinic №3; Institute for Advanced Training of Health Workers of the Khabarovsk TerritoryKrasnoyarsk State Medical University named after Prof. V.F. Voino-YasenetskyState Novosibirsk Regional Clinical HospitalResearch Institute of CardiologyO.N. Semashko Republican Clinical HospitalM.F. Vladimirsky Moscow Regional Clinical Research InstituteNovokuznetsk City Clinical Hospital №1; Novokuznetsk State Institute of Advanced Medical Studies – Branch of Russian Medical Academy of Continuing Professional EducationA.I. Yevdokimov Moscow State University of Medicine and DentistryRegional Clinical Cardiology DispensaryRostov State Medical UniversityKazan State Medical UniversityVoronezh Regional Clinical Hospital №1.Voronezh Regional Clinical Hospital №1.Irkutsk Regional Clinical HospitalSouth-Ural State Medical UniversityProf. S.V. Ochapovsky Research Institute – Regional Clinical Hospital №1National Medical Research Center for Therapy and Preventive MedicineI.M. Sechenov First Moscow State Medical University (Sechenov University)Novosibirsk Regional Clinical Cardiology Dispensary; Novosibirsk State Medical UniversityAim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy or in combination with hydrochlorothiazide or amlodipine, in real clinical practice in patients with diagnosed arterial hypertension who have not reached the target levels of blood pressure (BP).Material and methods. The study was a non-intervention, prospective, multicenter, comparative, observational, epidemiological program, which was carried out in Russian medical institutions. The total patient population in which the prescribed therapy was administered included 1933 people (758 men and 1175 women, mean age 57.0-59.3 years). Participants were followed-up for 12 weeks. The change in office BP was evaluated on the 4th and 12th week.Results. Significant (p<0.001 in all cases) change in office BP compared with the initial data were recorded in all study groups of therapy already at 4 weeks of treatment and became even more pronounced at 12 weeks. In the telmisartan monotherapy group, BP decreased from 155.7±10.7/92.2±7.6 mm Hg to 131.4±12.1/80.8±7.3 mm Hg at the end of the 4th week and to 125.3±7.6/78.2±6.1 mm Hg – at the end of the 12th week. Similarly, after treatment with the combination of telmisartan and hydrochlorothiazide, BP decreased from 162.7±12.6/94.3±7.9 mm Hg to 133.2±12.5/81.6±8.4 mmHg at the end of the 4th week and to 126.0±7.8/78.4±6.7 mm Hg – at the end of the 12th week. In telmisartan/amlodipine group, a decrease in BP also occurred, from 162.5±13.2/94.6±8.6 mm Hg to 132.8±14.5/81.3±7.5 mm Hg on the 4th week and to 125.4±8.7/78.4±5.6 mm Hg at the end of follow up (12 weeks). The proportion of patients who reached the target BP (<140/90 mm Hg) after treatment with telmisartan as monotherapy was 91.7%, after treatment with telmisartan+hydrochlorothiazide – 89.6%, after treatment with telmisartan+amlodipine – 92.8%. Throughout the program, prescribed therapy was well tolerated by patients. During the study, 47 adverse events (AEs) were recorded in 36 patients: 31 AEs with telmisartan monotherapy, 5 AEs with telmisartan/hydrochlorothiazide combination, and 11 AEs with telmisartan/amlodipine combination. Most of the AEs registered during the trial resolved by the end of the study, in four cases the date of AEs resolve is unknown, in two cases, at the time of completion of the study, AEs continued.Conclusion. In the TAINA study a high antihypertensive efficacy and a comparable favorable safety and tolerability profile of telmisartan, used as monotherapy and in combination with hydrochlorothiazide or amlodipine was determined.https://www.rpcardio.online/jour/article/view/2173arterial hypertensiontelmisartanamlodipinehydrochlorothiazidereal clinical practicesafetyoffice blood pressure |
| spellingShingle | O. D. Ostroumova A. I. Kochetkov F. T. Ageev G. S. Anikin E. Kh. Akhmetzyanova E. I. Bezuglova A. B. Bekoeva N. Yu. Borovkova N. G. Vinogradova E. V. Gorbunova A. A. Goryacheva E. S. Zhugrova O. A. Kislyak S. M. Klyashev V. P. Kuzmin A. A. Lipchenko G. V. Matyushin E. A. Mikhailova V. A. Nevzorova A. G. Obrezan T. A. Petrichko M. M. Petrova A. N. Reider A. N. Repin V. I. Sadovoy N. P. Sanina A. E. Skripchenko R. I. Stryuk I. V. Faiyance L. A. Khaisheva N. R. Khasanov R. A. Khokhlov E. E. Tsareva A. L. Cherkashina I. I. Shaposhnik I. A. Shelestova R. N. Shepel E. V. Shikh D. A. Yakhontov The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA Рациональная фармакотерапия в кардиологии arterial hypertension telmisartan amlodipine hydrochlorothiazide real clinical practice safety office blood pressure |
| title | The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA |
| title_full | The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA |
| title_fullStr | The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA |
| title_full_unstemmed | The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA |
| title_short | The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA |
| title_sort | effects of telmisartan and its combinations on office blood pressure results of prospective observational study taina |
| topic | arterial hypertension telmisartan amlodipine hydrochlorothiazide real clinical practice safety office blood pressure |
| url | https://www.rpcardio.online/jour/article/view/2173 |
| work_keys_str_mv | AT odostroumova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aikochetkov theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ftageev theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT gsanikin theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ekhakhmetzyanova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eibezuglova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT abbekoeva theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT nyuborovkova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ngvinogradova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT evgorbunova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aagoryacheva theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eszhugrova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT oakislyak theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT smklyashev theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT vpkuzmin theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aalipchenko theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT gvmatyushin theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eamikhailova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT vanevzorova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT agobrezan theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT tapetrichko theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT mmpetrova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT anreider theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT anrepin theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT visadovoy theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT npsanina theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aeskripchenko theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ristryuk theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ivfaiyance theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT lakhaisheva theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT nrkhasanov theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT rakhokhlov theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eetsareva theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT alcherkashina theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT iishaposhnik theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT iashelestova theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT rnshepel theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT evshikh theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT dayakhontov theeffectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT odostroumova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aikochetkov effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ftageev effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT gsanikin effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ekhakhmetzyanova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eibezuglova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT abbekoeva effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT nyuborovkova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ngvinogradova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT evgorbunova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aagoryacheva effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eszhugrova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT oakislyak effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT smklyashev effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT vpkuzmin effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aalipchenko effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT gvmatyushin effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eamikhailova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT vanevzorova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT agobrezan effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT tapetrichko effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT mmpetrova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT anreider effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT anrepin effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT visadovoy effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT npsanina effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT aeskripchenko effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ristryuk effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT ivfaiyance effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT lakhaisheva effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT nrkhasanov effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT rakhokhlov effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT eetsareva effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT alcherkashina effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT iishaposhnik effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT iashelestova effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT rnshepel effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT evshikh effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina AT dayakhontov effectsoftelmisartananditscombinationsonofficebloodpressureresultsofprospectiveobservationalstudytaina |